Email Updates

Search form

You are here

15 JUNE 2018 VOLUME 19 ISSUE 24

Media Coverage

  • There is no room for complacency when so much more remains to be done for HIV prevention and treatment. The task of breaking down barriers and building bridges needs greater commitment and impetus. Now is not the time to take the foot off the pedal of the global AIDS response if the United Nations Sustainable Development Goal target of a 90% reduction in HIV incidence by 2030 is to be met.

    June 15, 2018
    Science
  • A clinic in Abuja, run by the Institute for Human Virology, Nigeria, bills itself as "MSM friendly" and dodges the legal hurdles to test and treat this community for HIV and other sexually transmitted infections.

    June 15, 2018
    Science
  • A unique package of graphics looks at HIV/AIDS around the world using five different metrics. By these gauges, Nigeria, Russia, and Florida stand out from their neighbors and, in some cases, the entire world.

    June 15, 2018
    General
    Science
  • A research project in Benin City run by the Institute for Human Virology, Nigeria, is attempting to assess whether exposure to the virus—or to antiretroviral drugs taken by the mother and baby that thwart transmission—may cause harm.

    June 15, 2018
    Science
  • People with HIV whose viral load has been fully suppressed for at least two years have a significantly lower risk of developing any form of cancer than other people with HIV, but still retain a higher risk of developing cancer than HIV-negative people of a similar age, a study of US military veterans published in Annals of Internal Medicine shows.

    June 15, 2018
    aidsmap
  • Three researchers talk with PA editor Jeff Berry about ongoing HIV cure research within the ACTG, treatment interruptions, and when we might see a cure.

    June 15, 2018
    Positively Aware
  • Fear of others thinking they’re promiscuous, or that they’re already infected with HIV, is a barrier to many women who might benefit from pills that help prevent the infection, a US study suggests.

    June 14, 2018
    Reuters
  • The combination of dolutegravir and lamivudine was shown to be as effective as a dolutegravir-based combination of three drugs, GSK’s majority-owned ViiV Healthcare said on Thursday. It said its push for two-drug regimens addressed long-term toxicity concerns of people living with HIV by reducing the number of medicines.

    June 14, 2018
    Reuters
  • "Miami is the epicenter of the epicenter of HIV/AIDS in the United States," says Mario Stevenson, a virologist with a thick Scottish brogue who heads the infectious disease department at the University of Miami (UM) Miller School of Medicine, which shares a campus with Jackson Memorial. "There's no abatement in our upward slope."

    June 13, 2018
    Science
  • At this stage in the scale-up of US PrEP programs, it is important to systematically and comprehensively analyze and integrate knowledge about the successes of and the barriers to PrEP implementation. Our review provides a comprehensive analysis and informs the direction of PrEP implementation across a variety of settings.

    June 13, 2018
    Medical Research
  • In The Lancet HIV, Brandon Marshall and colleagues report the results of a modelling study that compared effectiveness of exclusive long-acting injectable PrEP implementation with that of exclusive oral PrEP implementation in a virtual population of men who have sex with men in Atlanta, GA.

    June 13, 2018
    Lancet HIV
  • In what may be the most drastic move to date, the Trump administration has decided it will not defend the law against a suit brought by Republican-controlled states that will end one of Obamacare’s most popular provisions: the ban on using pre-existing conditions as an excuse to deny coverage.

    June 13, 2018
    LGBTQ Nation
  • A smartphone app designed to improve care for people living with HIV has increased users’ consistency in doctor visits and improved their health outcomes, a new study has found.

    June 13, 2018
    Augusta Free Press
  • Mother-to-child transmission is only one part of Nigeria’s HIV epidemic. But that route of transmission epitomizes the country’s faltering response to the crisis, highlighting major gaps in HIV testing that allow infections to go untreated and the virus to spread.

    June 12, 2018
    Science
  • Abortion rights and PrEP prophylactics both allow for sex free of fear, which is exactly what opponents of sexual liberation don’t want.

    June 11, 2018
    The Village Voice
  • Almost anywhere in the world, an HIV-infected woman who has an uninfected partner and wants to have a baby would be first in line to receive ARVs. The challenges Katia faced in getting treatment amid Russia’s epidemic highlight the country’s faltering response, which critics have blasted as misguided, lackadaisical, and downright dismissive.

    June 11, 2018
    Science
  • Infection rates declined despite an rise in unprotected sex, suggesting widespread use of the drug may mitigate the effects of riskier behavior.

    June 11, 2018
    New York Times
  • Why did it take until 2015 for a prominent Russian to finally reveal that he was living with HIV? “We are still Soviet,” Lobkov says. “And we are still trying to keep our problems inside us.”

    June 11, 2018
    General
    Science
  • The decision to establish an African Medicines Agency is hailed as a turning point in efforts to advance regulatory oversight but also draws calls for caution.

    June 9, 2018
    General
    Lancet
  • In a precedent-setting ruling, the Supreme Court of Sweden ruled that "thorough treatment" minimized the risk of infection, thus making a dent in the divulgence requirement for the HIV-positive before having unprotected sex.

    June 8, 2018
    Sputnik News
  • The European Commission may be planning to hike spending for its flagship research programme, but health and scientific research, particularly into new vaccines, was not one of the winners from the proposal announced on Thursday.

    June 7, 2018
    HIV Vaccine, General, PrEP
    Euractiv
  • His hope is to see an HIV vaccine developed during his lifetime that could prevent those who are not infected from getting the disease, and also to address the burden of taking pills every day — for those already living with the virus.

    June 6, 2018
    General
    The East African

Published Research

Announcements